Skip to main content

Advertisement

SpringerLink
Log in

Radio-guided surgery for persistent differentiated papillary thyroid cancer: case presentations and review of the literature

  • Current Concepts in Endocrine Surgery
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background and aims

Persistent differentiated papillary thyroid cancer following radical locoregional surgery with metastases is an indication for limited reoperation or radioiodine therapy. Following injection of radioiodine, radio-guided surgery with application of an intraoperative gamma probe offers detection of metastases not seen by conventional imaging and control of completeness of resection.

Patients/methods

We demonstrate four patients with locoregional metastases, two of them with additional distant metastases of papillary thyroid cancer following radical neck surgery. Postoperative radioiodine scans demonstrated persistent ipsilateral or contralateral cervical and mediastinal lymph node and isolated rib metastases.

Results

Radio-guided surgery (RGS) leads to complete clearance of persistent lymph node metastases by limited recurrent neck surgery, resection of metastases not seen by conventional imaging and control of complete mediastinal lymph node dissection. Post-RGS scans allowed early diagnosis of occult diffuse or nodal pulmonary metastases in two patients. At last follow-up, 23 to 48 months following RGS and radioiodine therapy, there was no evidence of disease.

Conclusions

Radio-guided surgery is an additive surgical technique with low morbidity in selected patients with persistent thyroid cancer individualizing tumor therapy options in multimode oncological therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Pacini F, Cetani F, Miccoli P, Mancusi F, Ceccarelli C, Lippi F, Martino E, Pinchera A (1994) Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World J Surg 18(4):600–604

    Article  PubMed  CAS  Google Scholar 

  2. Chow SM, Law SC, Mendenhall WM, Au SK, Yau S, Yuen KT, Law CC, Lau WH (2002) Follicular thyroid carcinoma: prognostic factors and the role of radioiodine. Cancer 95(3):488–498

    Article  PubMed  Google Scholar 

  3. Taylor T, Specker B, Robbins J, Sperling M, Ho M, Ain K, Bigos ST, Brierley J, Cooper D, Haugen B, Hay I, Hertzberg V, Klein I, Klein H, Ladenson P, Nishiyama R, Ross D, Sherman S, Maxon HR (1998) Outcome after treatment of high-risk papillary and non-Hurthle-cell follicular thyroid carcinoma. Ann Intern Med 129(8):622–627

    PubMed  CAS  Google Scholar 

  4. Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97(5):418–428

    Article  PubMed  CAS  Google Scholar 

  5. Coburn M, Teates D, Wanebo HJ (1994) Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131). Ann Surg 219(6):587–593

    Article  PubMed  CAS  Google Scholar 

  6. Maxon HR III, Englaro EE, Thomas SR, Hertzberg VS, Hinnefeld JD, Chen LS, Smith H, Cummings D, Aden MD (1992) Radioiodine-131 therapy for well-differentiated thyroid cancer—a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med 33(6):1132–1136

    PubMed  Google Scholar 

  7. Casara D, Rubello D, Saladini G, Masarotto G, Favero A, Girelli ME, Busnardo B (1993) Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 34(10):1626–1631

    PubMed  CAS  Google Scholar 

  8. Thyroid Carcinoma Task Force (2001) AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract 7(3):202–220

    Google Scholar 

  9. Deutsche Krebsgesellschaft und Deutsche Gesellschaft für Chirurgie (2002) Maligne Schilddrüsentumoren. Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Chirurgie, 3rd Auflage. Deutsche Krebsgesellschaft

  10. Travagli JP, Cailleux AF, Ricard M, Baudin E, Caillou B, Parmentier C, Schlumberger M (1998) Combination of radioiodine (131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma. J Clin Endocrinol Metab 83(8):2675–2680

    Article  PubMed  CAS  Google Scholar 

  11. Goretzki PE, Simon D, Frilling A, Witte J, Reiners C, Grussendorf M, Horster FA, Roher HD (1993) Surgical reintervention for differentiated thyroid cancer. Br J Surg 80(8):1009–1210

    Article  PubMed  CAS  Google Scholar 

  12. Röher HD, Goretzki PE (1988) Surgical treatment of distant metastases from differentiated thyroid cancer. Prog Surg 19:113–132

    Google Scholar 

  13. Wood WJ Jr, Singletary SE, Hickey RC (1989) Current results of treatment for distant metastatic well-differentiated thyroid carcinoma. Arch Surg 124(12):1374–1377

    PubMed  Google Scholar 

  14. Romer W, Florack G, Schwaiger M, Langhammer HR (2002) Multimodal therapy concept in advanced distant metastasis of a follicular thyroid carcinoma. Nuklearmedizin 41(3):N27–N29

    PubMed  CAS  Google Scholar 

  15. Gallowitsch HJ, Fellinger J, Mikosch P, Kresnik E, Lind P (1997) Gamma probe-guided resection of a lymph node metastasis with I-123 in papillary thyroid carcinoma. Clin Nucl Med 22(9):591–592

    Article  PubMed  CAS  Google Scholar 

  16. Mansberg R, Crawford B, Uren RF, Thompson JF (2005) Minimally invasive radio-guided surgery for recurrent thyroid cancer using iodine-123. Clin Nucl Med 30(1):43–44

    Article  PubMed  Google Scholar 

  17. Littmann K, Magdsick G, Strotges MW, Eigler FW (1980) Intraoperative localization measurement following preoperative radioiodine marking to facilitate the treatment of differentiated thyroid carcinoma. Chirurg 51(6):389–394

    PubMed  CAS  Google Scholar 

  18. Lippi F, Capezzone M, Miccoli P, Traino C, Di Martino F, Angelini F, Spinelli C, Iacconi P, Pinchera A, Pacini F (2000) Use of surgical gamma probe for the detection of lymph node metastases in differentiated thyroid cancer. Tumori 86(4):367–369

    PubMed  CAS  Google Scholar 

  19. Rubello D, Piotto A, Pagetta C, Pelizzo MR, Casara D (2002) (99m)Tc-MIBI radio-guided surgery for recurrent thyroid carcinoma: technical feasibility and procedure, and preliminary clinical results. Eur J Nucl Med Mol Imaging 29(9):1201–1205

    Article  PubMed  CAS  Google Scholar 

  20. Salvatori M, Rufini V, Reale F, Gajate AM, Maussier ML, Revelli L, Troncone L, Ardito G (2003) Radio-guided surgery for lymph node recurrences of differentiated thyroid cancer. World J Surg 27(7):770–775

    Article  PubMed  Google Scholar 

  21. Schachter P, Shimonov M, Lorberboim M (2005) Combined radioiodine (I131) treatment and radio-guided surgery for recurrent cervical well-differentiated thyroid cancer. Harefuah 144(3):168–172 (232, 231)

    PubMed  Google Scholar 

  22. Coburn MC, Wanebo HJ (1992) Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg 164(6):671–676

    Article  PubMed  CAS  Google Scholar 

  23. Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB (1998) The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 82(2):375–388

    Article  PubMed  CAS  Google Scholar 

  24. Dewan SS, Sharma SM, Ganatra RD (1979) Radioiodine in treatment of metastatic thyroid cancer. Int J Nucl Med Biol 6(4):213–214

    Article  PubMed  CAS  Google Scholar 

  25. Ceccarelli C, Pacini F, Lippi F, Elisei R, Arganini M, Miccoli P, Pinchera A (1988) Thyroid cancer in children and adolescents. Surgery 104(6):1143–1148

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We are very grateful for the technical assistance of Johannes Schmal in preparing graphs and of Susanne Brunnhölzl in preparing the manuscript.

Author information

Authors and Affiliations

  1. Department of Surgery, Interdisciplinary Center for Thyroid Diseases, Klinikum rechts der Isar, University of Polytechnique, Ismaninger Strasse 22, 81675, Munich, Germany

    T. Negele, T. Brückner & H. Vogelsang

  2. Department of Nuclear Medicine, Interdisciplinary Center for Thyroid Diseases, Klinikum rechts der Isar, University of Polytechnique, Munich, Germany

    G. Meisetschläger, K. Scheidhauer & M. Schwaiger

Authors
  1. T. Negele
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Meisetschläger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Brückner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Scheidhauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Schwaiger
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Vogelsang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Vogelsang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Negele, T., Meisetschläger, G., Brückner, T. et al. Radio-guided surgery for persistent differentiated papillary thyroid cancer: case presentations and review of the literature. Langenbecks Arch Surg 391, 178–186 (2006). https://doi.org/10.1007/s00423-005-0013-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-005-0013-5

Keywords

Search

Navigation